GF Securities

GF Securities Co., Ltd., established in 1993 and headquartered in Guangzhou, China, provides a comprehensive range of capital market services to corporations, individuals, institutional investors, financial institutions, and government clients. The company operates through four main segments: Investment Banking, Wealth Management, Trading and Institution, and Investment Management. Its Investment Banking segment offers services such as equity and debt financing, financial advisory for mergers and acquisitions, and restructuring. The Wealth Management segment focuses on brokerage services for trading various securities, along with margin financing and securities lending. The Trading and Institution segment engages in the trading of equities, fixed income, and derivatives, while providing transaction consultation, investment research, and asset custody services. Finally, the Investment Management segment offers asset management and mutual fund management, along with investment consulting and trust management services. GF Securities is recognized for its extensive expertise in facilitating financial transactions and advisory services within the Chinese capital markets.

Evan Shen

Equity Research Analyst

50 past transactions

Sanyou Medical

Post in 2025
Shanghai Sanyou Medical Co., Ltd specializes in the research and development, manufacturing, and sales of innovative orthopedic implants and medical devices. The company is located in the Medical Apparatus Garden of Zhangjiang Hi-Tech Park in Shanghai. Its product range includes type III implantation equipment for orthopedics, type III intracranial hematoma puncture removal equipment, as well as various types of surgical instruments and nursing materials. Since its restructuring in September 2010, the company has aimed to establish a sustainable and valuable presence in the medical device industry.

Xunchi Xunjie

Series A in 2025
Xunchi Xunjie is a new energy vehicle charging pile R&D and operation operator.

Benlizu

Seed Round in 2024
Benlizu is a one-stop provider of office smart equipment leasing services, committed to offering corporations and government departments with low-cost and high-efficiency leasing options.

Noematrix

Seed Round in 2024
Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.

DFD

Post in 2023
DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides.

Regenex Corporation

Series C in 2023
Regenex Corporation Co. Ltd. is a pharmaceutical company based in Guangzhou, China, focused on the research, development, and manufacture of a diverse range of medical products. The company specializes in reproductive health medicines, including oral contraceptives such as levonorgestrel enteric-coated tablets and emergency contraceptives, along with condoms that contain water-based lubricants. Additionally, Regenex produces anti-neoplastic drugs, including hydrochloric acid doxorubicin liposome injections, and antibiotic agents like Amphotericin B liposome for injection. The company also develops medications for chronic diseases and geriatric care. Founded in 2003, Regenex emphasizes innovative practices in its marketing strategies, including GPS track management for its personnel.

Value Partners Group

Secondary Market in 2023
Value Partners Group is an independent asset management firm founded in 1993 by Cheah Cheng Hye and Yeh V-Nee. It specializes in traditional value-style investing, focusing primarily on the Asia-Pacific region, particularly the Greater China markets. The firm has established itself as one of Hong Kong's largest home-grown investment managers, offering a range of asset management portfolios for both institutional and individual clients across Asia Pacific, Europe, and the United States. Its product offerings include absolute return funds, fixed-income products, long-short hedge funds, exchange-traded funds, and quantitative funds. Value Partners Group generates inflows through a distribution network that encompasses retail banks, private banks, and insurance companies, with retail investors being the primary contributors to its funds. Additionally, the firm provides opportunities for white-label and co-branded funds, further expanding its reach in the asset management industry.

Viiyong

Series B in 2022
Viiyong is a manufacturer based in Shenzhen, China, specializing in multi-layer ceramic chip capacitors. Established in 2001, the company emphasizes research and development to produce high-end capacitors tailored for the automotive electronics sector. By focusing on advanced technology and innovation, Viiyong aims to meet the specific needs of its customers in this industry.

Wensheng AMC

Private Equity Round in 2022
Wensheng AMC specializes in investment and management services focused on special opportunities within the financial sector. Its primary activities include the investment in non-performing assets, management of distressed enterprises, restructuring of troubled real estate, and investment in defaulted bonds. By offering these services, Wensheng AMC aims to facilitate the recovery and enhancement of value in alternative asset targets, enabling clients to achieve potential gains from their specialized investment strategies.

Volastra

Seed Round in 2020
Volastra Therapeutics, Inc. is a biotechnology company based in New York that focuses on developing therapies for metastatic cancers. Founded in 2019, the company utilizes a library of organoids derived from metastatic cancer samples to understand tumor spread and create targeted therapeutic strategies aimed at chromosomal instability. By integrating artificial intelligence, bioinformatics, and proprietary imaging techniques, Volastra identifies cancers at higher risk of metastasis, allowing healthcare professionals to select appropriate patients for therapy and improve treatment outcomes. Through its innovative approach, Volastra seeks to advance the understanding and management of metastatic diseases.

Pi Therapeutics

Series B in 2019
Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and has operated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.

Sitka Biopharma

Venture Round in 2018
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues. Initially targeting oncology indications, we are developing our lead candidate (STK-01) to address the absorption challenge of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer. Their nanoparticle platform technology is highly versatile, offers unique benefits over other nano-delivery systems, and is particularly well-suited for treating relatively localized diseases where local administration of the therapeutic is possible but is currently ineffective or unsafe. Bladder cancer was chosen for their lead program because it is characterized by therapies that exhibit limited uptake and efficacy, or are associated with significant tolerability issues and side effects. Sitka’s novel product (STK-01) is designed to overcome these issues and improve treatment outcomes by delivering a much higher concentration of the chemotherapeutic docetaxel into the bladder wall.

Chinac.com

Series E in 2018
Chinac.com, also known as 华云数据, is a Chinese cloud computing infrastructure operator that specializes in the research, development, and operation of commercial cloud solutions. The company offers a range of IT solutions and outsourcing services to both domestic and global clients, functioning as a SaaS and PaaS provider, as well as a traditional software development company and system integrator. Chinac.com supports various sectors, including online gaming, e-commerce, mobile internet, online education, and social networking. The company boasts extensive resources, with tens of thousands of physical server clusters and 20 data centers across more than 15 cities in China. Its network infrastructure is integrated with major telecommunications providers, ensuring robust connectivity for its clients.

Canary Medical

Venture Round in 2018
Canary Medical Inc. focuses on developing innovative medical implant and data management devices that facilitate remote patient monitoring and data collection. Founded in 2013 and based in Vancouver, Canada, the company has created the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device that autonomously gathers medical data without requiring significant patient compliance or physician intervention. In 2021, it launched canturio™te, the first "smart knee" tibial extension, which continuously monitors patient activity and joint performance, transmitting the collected data to the cloud. Canary Medical aims to enhance healthcare outcomes while reducing costs by providing reliable and efficient healthcare data monitoring and analysis. The company is backed by a team of experienced professionals with expertise in medical device design, development, and data informatics.

Yixiaoshi Kuaixiu

Series A in 2018
One-hour technology is a mobile phone repair service chain organization, mainly in the form of mobile phone repair + accessories, through the development of four systems (repair, change, buy it, sell it), using the official website, WeChat public account, APP and other channels Online consultation and service appointments, as well as on-site maintenance services such as screen change, battery replacement, chip replacement, and mobile phone recycling, trade-in and other services

ARTMS

Venture Round in 2017
ARTMS is a technology developer focused on transforming the production of diagnostic imaging isotopes. The company has created the QUANTM Irradiation System, which supports decentralized and local production of essential medical isotopes such as gallium-68, zirconium-89, technetium-99m, and copper-64. This innovative technology allows for cost-effective, high-yield production using local hospital-based medical cyclotrons, thereby enabling the nuclear medicine industry to better manage supply chain demands and enhance the availability of critical imaging agents. Through its advancements, ARTMS aims to improve access to important diagnostic tools in healthcare.

Bioarray Therapeutics

Series B in 2017
BIOARRAY's Therapeutics, Inc. (BIOARRAY) is a privately held start up biotechnology company founded in 2009 in Boston, MA. BIOARRAY is developing proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used.

Fotor

Series B in 2017
Fotor is an online multi-platform photo editing tool. It gains popularity with optimized and user-friendly desktop suit for both Windows and Mac, Fotor now supports every major mobile and desktop platform from Android to iOS, with a specialized Fotor for Messenger version, streamlined with Facebook for connectivity and convenience. Fotor comprises of many features such as photo editing, photo collage, graphic design, HDR, and beauty retouching. Digital editing services that includes resizing, cropping, and straightening and a wide range of filters and effects such as lomo effects, cool effects, funky effects, and blur effects are offered through the platform. Designing of a collage expresses stories, special feelings, and even captures an individual’s life. The sub categories of collage are photo stitching and funky collages. It also helps individuals design Twitter covers, YouTube channel art, Facebook covers, Google Plus covers, and a photo montages. HDR Photography utilizes different level of light exposure to enhance an image. Beauty retouching comprises of photo correcting services such as wrinkle remover, photo reshaping, blemish remover, and teeth whitener. Fotor is a China-based company that was launched in 2012.

PhysIQ

Series B in 2017
PhysIQ, Inc. is a health technology company based in Chicago, Illinois, that specializes in a cloud-based predictive platform for personalized physiology analytics. The company has developed a platform that analyzes multiple data streams to establish individual baseline norms for patients, allowing clinicians to monitor vital signs and detect clinically significant changes. This innovative approach helps manage chronic illnesses by predicting acute medical events before symptoms arise and empowers consumers to take control of their health and fitness. PhysIQ's solution is applicable in both regulated healthcare and unregulated health and fitness markets, and it can be integrated into other patient monitoring devices, enhancing their capabilities. Founded in 2013, PhysIQ was previously known as VGBio, Inc.

PHEMI

Series B in 2017
The PHEMI Trustworthy Health DataLab is a unique, cloud-based, integrated big data management system that allows healthcare organizations to enhance innovation and generate value from healthcare data by simplifying the ingestion and de-identification of data with NSA/military-grade governance, privacy, and security built-in.

Eloxx

Series C in 2017
Eloxx Pharmaceuticals based in Israel is a Pontifax portfolio company established in 2013 by Dr. Silvia Noiman, that serves as its Executive Chairman and Dr. Shmuel Tuvia. The company, is a biopharmaceutical company focused on discovery, development and commercialization of compounds for the treatment of genetic diseases caused by nonsense mutations including: Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, Tay-Sachs Hurler syndrome and many others. Eloxx Pharmaceuticals approach and knowhow allows moving rapidly from target drugs discovery program to clinical drug candidates. Building a robust pipeline of molecules designed for an array of nonsense genetic diseases. Translation of mRNA to a protein is the event where the cellular machinery, i.e. ribosome, ultimately dictates the quantity and timing for each protein to be produced. Thus, molecules that induce ribosomal readthrough overcome the nonsense mutations and allow production of a full-length functional protein. These molecules hold great therapeutic potential for the treatment of many genetic diseases.

CheVIP.com

Series A in 2017
Weiche E-Commerce is an intelligent service platform for second-hand car transactions. They provide customers with online second-hand car transaction services, inspection services, management software services, auction services for enterprises and institutions, transfer agency and logistics services, vehicle data inquiries, and derivative financial products.

Lyndra Therapeutics

Series A in 2017
Lyndra Therapeutics, Inc. is a biotechnology company that specializes in the development of ultra-long-acting oral medicines. Founded in 2015 and headquartered in Watertown, Massachusetts, the company focuses on creating orally administered dosage forms that can deliver a sustained release of medications for periods ranging from a week to a month while remaining in the stomach. Lyndra's therapeutic initiatives target a variety of conditions, including Alzheimer's disease, cardiovascular and metabolic disorders, psychiatric issues, opioid use disorders, immunology, HIV, malaria vector control, and oral contraceptives. By enhancing medication adherence and improving health outcomes, Lyndra Therapeutics aims to contribute to lower healthcare costs and better patient care.

Hongjing International Education

Series A in 2017
Hongjing International Education is an e-learning platform. They provide products that include finance, medical, legal, financial, and IT engineering. Their customers' inquiries are addressed through phone, email, and online applications.

PingPong

Series B in 2017
PingPong is a financial services company that supports international eCommerce sellers by facilitating cross-border payments. Founded in 2015, it has become a trusted partner for over 750,000 online merchants globally, processing more than 90 billion USD in transactions to date. The platform allows sellers to reduce expenses associated with international payments, value-added tax (VAT), and supplier payments. By offering a free account, PingPong enables users to manage marketplace profits more efficiently than traditional banks, streamlining operations through a single interface. The company collaborates with major financial institutions, ensuring compliance with regulatory standards in the U.S., Europe, and Asia while enhancing operational efficiencies for its clients.

Guangdong Flying Enterprise Internet Technology Co., Ltd.

Post in 2017
Guangdong Flying Enterprise Internet technology offers innovative services for the intelligent construction of national parks. It focuses on the top design, planning, construction, and operation of smart parks and uses the Internet of Things, blockchain, artificial intelligence, cloud computing, and other cutting-edge technologies to help parks achieve digital transformation.

Biscayne Pharmaceuticals

Series B in 2017
Biscayne Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops therapies based on growth hormone-releasing hormone (GHRH) analogs. The compounds include GHRH antagonists in development for the treatment of cancer, including castrate-resistant prostate cancer, and GHRH agonists for the repair of cardiac damage in heart disease patients. The company was incorporated in 2012 and is headquartered in Miami, Florida.

iGola

Series A in 2016
iGola is a smart metasearch engine that allows users to search for and book international air tickets from providers worldwide. iGola provides live price comparison and facilitated booking, all delivered with a clean and intuitive user experience, helping travelers to complete their booking from hundreds of airlines without redirecting.

Youjian

Series A in 2016
Youjian is a haircut services platform. They provide hairdressing services along with other hair related services, enabling customers to avoid market distractions and upgrade their haircut experience.

SocialCredits

Seed Round in 2016
SocialCredits develops a multi-dimensional product system for small and micro-inclusive digitization, government and enterprise digitization, and digital economy industry operations.

Helowin

Series E in 2016
Zhejiang Helowin Medical Technology Co., Ltd. was founded in 2006 with an RMB 134 million registered capital. Since its inception, the chairman Sun Bin, the founder of Helowin, has led all employees in providing professional medical and health management services to thousands of families, with the goal of creating a health bridge between doctors and patients. After 12 years of hard work, Helowin has evolved into a national high-tech enterprise that combines "wireless intelligent data collection terminal research and development + medical health big data cloud platform construction + medical health service mining," with a business model that has expanded from B2B to B2B2C and B2C.

Loving Medical

Series A in 2016
Loving Medical is a medical service enterprise with innovative service models.

Liaoning Chengda Biological

Post in 2016
Liaoning Chengda Biotechnology Co., Ltd. is an international advanced virus vaccine production technology platform introduced from the United States. It was established in Shenyang in June 2002 as a high-tech enterprise. Companies adhering to the "integrity integrity, benevolence and harmony" of the core values, is committed to research and development, production and promotion of "international level, domestic leading" biological products, the main products for Chengda speed up human rabies vaccine and Chengda Libao people type B Encephalitis inactivated vaccine. Chengda Bio was listed on the New Third Board on December 31, 2014 with a registered capital of 360 million. It is controlled by Liaoning Chengda Co., Ltd. (600739), and its profitability and appreciation potential are among the top three new board companies. The production base is located in the National High-tech Park of Weinan, Shenyang, covering an area of ​​nearly 100 acres, with a construction area of ​​over 50,000 square meters and more than 800 employees. There are 4 stock solutions workshops, 3 preparation workshops and a pilot plant. The annual production capacity of human rabies vaccine reaches 10 million, and the annual production capacity of Japanese encephalitis vaccine is 10 million. All workshops have successfully passed the 2010 national new GMP certification. Chengda Bio is a family vaccine manufacturer. Chengda Suida rabies vaccine has always maintained a leading position in the domestic market, and has been exported to India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, etc. Countries. Chengda Libao JE vaccine is currently the only inactivated Japanese encephalitis vaccine in China and has been successfully exported to Thailand and registered in Cambodia. The bivalent renal syndrome hemorrhagic fever vaccine (Vero cells) independently developed based on the core technology platform has completed clinical research work, and the target is to obtain the production batch number in 2022 and pass the GMP acceptance. On the one hand, Chengda Bio has accelerated the expansion of its product line, supplemented the conventional vaccine varieties at a high starting point, and actively promoted the development of multi-linked multi-valent vaccines and innovative vaccines around the country's expansion of the immunization program vaccine supply system. Chengda Bio has always adhered to the values ​​of “integrity and responsibility”, established brand awareness and reputation in both domestic and international markets, adhered to the “international level, domestic leading” product positioning, and strived to become trustworthy and respectful in the industry. A company with significant influence.

XUANWU TECHNOLOGY

Post in 2016
Xuanwu Technology is a Chinese enterprise focused on mobile information services and intelligent customer relationship management (CRM). With nearly two decades of experience, the company specializes in mobile informatization research and the development of innovative mobile cloud platforms. It operates under a dual-core strategy of "cloud communication + cloud management," aiming to transform enterprise management through mobile internet technology. Xuanwu Technology offers comprehensive mobile informatization solutions through its brands, Jixin and Xuanxun, catering to various corporate clients. Additionally, the company provides CRM Platform as a Service (PaaS) and Software as a Service (SaaS), which include messaging communication capabilities and tools for marketing, sales, and customer service. This enables businesses to streamline their operations and enhance customer engagement throughout their entire business cycle.

KOTEI

Post in 2016
Wuhan Kotei Informatics Co., Ltd. specializes in the development of software solutions for smart cars and smart cities. Founded in 2011 and based in Wuhan, China, the company offers a range of products including navigation software for vehicles and mapping applications for smartphones. KOTEI provides industry-specific navigation systems tailored for sectors such as power, logistics, and law enforcement, enhancing functionalities through aerial photo displays and business flow processing features. Additionally, the company develops smart city management solutions, which encompass smart land supervision, tourism data systems, and tax management systems. KOTEI is also dedicated to research and development in automotive electronics software technologies, offering integrated solutions that include smart cockpit, smart driving, and digital maps for intelligent and connected vehicles.

Oteao

Series B in 2016
Oteao is a B2B marketplace platform for the tea industry.

Since Times

Post in 2016
Since Times is a digital interactive entertainment company that focuses on the development of online games, particularly for the Tencent platform. The company specializes in creating a variety of gaming experiences, including social games, mobile games, and web games. By integrating different types of games, Since Times aims to provide engaging entertainment for gamers within the Tencent ecosystem.

JAKI

Post in 2016
JAKI product research and development, and promotes development. They provides delivery services like .211 limited time, delivery service inquiry, shipping fee charging standard and overseas delivery. They also provides online education for the kids.

Micro Communication

Post in 2016
Micro Communication is a technology-driven company with a technical development team that provides customers with pre-sales and after-sales services. There has always been a connection between the platform resource accounts and social media marketing. The characteristics of self-mediated communication are combined with a programme system with automatic execution, artificial follow-up supervision, and an intervention mode to ensure that the communication is carried out.

Tellyes Scientific

Post in 2015
Tellyes Scientific Inc. specializes in the manufacture and marketing of healthcare equipment aimed at the medical education and training sectors. Founded in 2001 and headquartered in Tianjin, China, the company offers a diverse range of products, including patient simulators, surgical simulators, ultrasound and imaging simulators, task trainers, and dental simulators. Tellyes Scientific also provides solutions for planning and managing training centers and engages in tele-simulation. The company's innovative approach encompasses research and development in various fields, including training software and traditional Chinese medicine training systems. With a portfolio of over a thousand types of medical virtual teaching products, Tellyes Scientific serves a global market through a network of distributors across Asia, Africa, the Middle East, Europe, North America, and Latin America.

Source Homo Technology

Post in 2015
Source Homo Technology is a technology company that specialises in the development of image detection systems and intelligent robotics solutions. Their expertise lies in creating solutions that combine image recognition technology with intelligent robotics, catering to various industries' needs. Source Homo Technology offers state-of-the-art products and services to enhance efficiency and productivity in diverse sectors.

Source Homo Technology

Post in 2015
Source Homo Technology is a technology company that specialises in the development of image detection systems and intelligent robotics solutions. Their expertise lies in creating solutions that combine image recognition technology with intelligent robotics, catering to various industries' needs. Source Homo Technology offers state-of-the-art products and services to enhance efficiency and productivity in diverse sectors.

Anhui Tongyu Electronics

Post in 2015
Anhui Tongyu Electronics designs, produces, sells, and services automotive electronic products. Body domain control (including body controller, lighting domain controller, intelligent junction box, engine immobilizer control unit, car remote control key, keyless entry, keyless start, ripple anti-pinch, central gateway, etc.) and seat control (driving environment controller, seat controller, seat adjustment switch assembly, rearview mirror controller, etc.) are the company's main products. Anhui Tongyu Electronics implements a quality management system, controls the entire process, forms a complete quality management system, and earns customers' trust through high-quality products and excellent services.

Tiandi

Post in 2015
Tiandi It develops and produces vinegar-based beverages. The company's major offerings, which give clients nutritious mealtime beverages, include vinegar drinks, cider, and natural spring water. is a joint-stock company that combines vinegar beverage research and development, production, and sales.

Centran

Post in 2015
Centran develops platforms for intelligent command and decision-making systems. It has control over AI, cloud computing, the Internet of Things, and other government-supported technology. They offer customers solutions for digital transformation through product manufacture, application system development, integration, and technical services. They maintain the significance of digital solutions for diverse industries, provide clients with services and value that take advantage of technology, and generate economic and social benefits.

Launch Design

Post in 2015
Launch Design is an automotive design company specializing in comprehensive research and development services. It offers a range of capabilities including styling, body design, interior and exterior trim, chassis development, electrical systems, performance analysis, and prototype production. The firm employs a professional technology team with expertise in vehicle integration, complete vehicle model design, engineering development, and design verification. By providing long-term research and development and consulting services, Launch Design supports automotive production enterprises in enhancing their vehicle offerings.

Dongyang Kingrain Media Co., Ltd.

Post in 2015
Dongyang Kingrain Media Co., Ltd., established in 2007 and headquartered in Beijing, China, specializes in the production and distribution of television dramas. The company is recognized for its investment in high-quality TV series, having successfully released notable titles such as "Hunting Field," "Latent," "The Lancet," "Borrowing a Gun," "Eagle 1949," and "Flying Tiger." In addition to production, Dongyang Kingrain Media offers distribution and licensing services for its television content, as well as advertising services. The company's team is composed of industry professionals who emphasize a commitment to aesthetic excellence and social responsibility in their projects.

Toone

Post in 2015
Toone is a smart city construction and operation solutions provider company.

Zhihong Logistics

Angel Round in 2014
Zhihong Logistics, founded in 2003 and headquartered in Guangzhou, Guangdong, specializes in logistics transportation services and offers a range of value-added services. These services include vehicle collection, trailer rental, and vehicle management, all designed to enhance the efficiency and quality of transportation and delivery for customers. By focusing on these areas, Zhihong Logistics aims to meet the diverse needs of its clientele in the logistics sector.

Guangyuyuan

Post in 1996
GuangYuYuan Chinese Herbal Medicine is a biotech company whose main business is the production and distribution of health wine and traditional Chinese medicine. Traditional Chinese medicine, fine Chinese medicine, and health wine are among the product categories offered by the company. These products include Dingkun Dan, Guilingji, Angong Niuhuang Pills, and Niuhuang Qingxin Pills, among others. The business sells its goods on the domestic market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.